- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/452 - Piperidinium derivatives
Patent holdings for IPC class A61K 31/452
Total number of patents in this class: 133
10-year publication summary
|
5
|
9
|
5
|
14
|
17
|
15
|
11
|
5
|
2
|
5
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Nocion Therapeutics, Inc. | 51 |
12 |
| Satiogen Pharmaceuticals, Inc. | 12 |
5 |
| Fosun Orinove Pharmatech, Inc. | 12 |
5 |
| Takeda Pharmaceutical Company Limited | 2715 |
4 |
| Amicus Therapeutics, Inc. | 354 |
4 |
| University of Florida Research Foundation, Inc. | 4173 |
3 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2292 |
3 |
| LTT Bio-Pharma Co., Ltd. | 45 |
3 |
| West China Hospital, Sichuan University | 237 |
3 |
| Lophora ApS | 8 |
3 |
| Libertas bio, Inc. | 22 |
3 |
| The General Hospital Corporation | 4858 |
2 |
| Asana Biosciences, LLC | 42 |
2 |
| Barry University, Inc. | 4 |
2 |
| Case Western Reserve University | 1888 |
2 |
| Children's Medical Center Corporation | 1956 |
2 |
| Dana-Farber Cancer Institute, Inc. | 2662 |
2 |
| Khondrion IP B.V. | 20 |
2 |
| Korea Research Institute of Chemical Technology | 1469 |
2 |
| PnP Biopharm Co., Ltd. | 18 |
2 |
| Other owners | 67 |